Back to ARWR overview

ARWR Arrowhead Pharmaceuticals PE ratio, current and historical analysis

The current PE ratio of ARWR cannot be calculated, as the latest EPS of -$4.24 is negative. Arrowhead Pharmaceuticals's last PE ratio on record was 287.7 in March 2020.

ARWR PE ratio history

How has ARWR's PE ratio performed in the past

The mean historical PE ratio of Arrowhead Pharmaceuticals over the last six years is 145.59. Looking back at the last six years, ARWR's PE ratio peaked in the Mar 2020 quarter at 287.7, with a price of $28.77 and an EPS of $0.1. The Sep 2019 quarter marked the lowest point at 39.14, with a price of $28.18 and an EPS of $0.72.

Average
145.59
Median
115.33
Minimum
39.14
Maximum
287.7

Arrowhead Pharmaceuticals PE ratio by year

Year PE ratio Change
2023 N/A N/A
2022 N/A N/A
2021 N/A N/A
2020 N/A N/A
2019 39.14 N/A
2018 N/A N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

ARWR average PE ratio chart

What is the average PE ratio of ARWR for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
145.59
15-year avg
N/A

ARWR PE vs peers

What is ARWR's PE ratio compared to its peers
Stock name PE ratio Market cap
JNJ Johnson & Johnson 9.9 $363.41B
LGND Ligand Pharmaceuticals Inc 15.99 $1.57B
ALNY Alnylam Pharmaceuticals Inc N/A $18.88B
INO Inovio Pharmaceuticals Inc N/A $286.83M
NANX NANOPHASE TECHNOLOGIES Corp N/A $31.6M
MRNA Moderna Inc N/A $54.34B
ARWR Arrowhead Pharmaceuticals Inc N/A $3.09B

Frequently asked questions

What is Arrowhead Pharmaceuticals's PE ratio?

The current price to earnings ratio of ARWR cannot be determined, as its EPS of -$4.24 is negative.

What is the highest PE ratio for ARWR?

The highest quarterly PE ratio in the last six years has been 287.7 and it was in the Mar 2020 quarter.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.